Filing Details
- Accession Number:
- 0001127602-21-004975
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-10 16:55:57
- Reporting Period:
- 2021-02-08
- Accepted Time:
- 2021-02-10 16:55:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1703647 | Frequency Therapeutics Inc. | FREQ | Pharmaceutical Preparations (2834) | 472324450 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1785288 | L. David Lucchino | C/O Frequency Therapeutics, Inc. 19 Presidential Way, 2Nd Floor Woburn MA 01801 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-02-08 | 16,554 | $0.61 | 324,640 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-08 | 5,518 | $52.50 | 319,122 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-08 | 5,518 | $55.00 | 313,604 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-08 | 5,518 | $57.50 | 308,086 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2021-02-08 | 16,554 | $0.00 | 16,554 | $0.61 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 171,441 | 2028-05-21 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2020.
- The option vests and becomes exercisable in equal monthly installments over a four year period commencing on February 1, 2018, and will be fully vested and exercisable on January 1, 2022.
Billionaire Hedge Funds
